Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study

被引：0
|
作者：
Mingot-Castellano, Maria Eva [1 ]
Alvarez-Roman, Maria Teresa [2 ]
Lozano, Maria Luisa [3 ]
Miesbach, Wolfgang [4 ]
Qureshi, Hafiz [5 ]
Mcdonald, Vickie [6 ]
Putnik, Milica [7 ]
Zhang, Jessica [8 ]
Skuban, Nina [8 ]
Garcia, Viridiana Cano [8 ]
Lethagen, Stefan [7 ]
机构：
[1] Hosp Univ Virgen Rocio, Seville, Spain
[2] Hosp Univ La Paz, Madrid, Spain
[3] Hosp Univ Morales Meseguer, Murcia, Spain
[4] Univ Hosp Frankfurt, Frankfurt, Germany
[5] Univ Hosp Leicester NHS Trust, Leicester, England
[6] Guys & St Thomas NHS Fdn Trust, London, England
[7] Sobi, Stockholm, Sweden
[8] Sobi, Waltham, MA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203491
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [1] Interim Baseline Characteristics of Adult Patients with Immune Thrombocytopenia Enrolled in the Observational Multicenter Phase 4 Adopt Study to Evaluate the Use and Effectiveness of Avatrombopag
    Ghanima, Waleed
    McDonald, Vickie
    Putnik, Milica
    Jamieson, Brian
    Lethagen, Stefan Rune
    BLOOD, 2023, 142
  • [2] Rationale and Design of an Observational Multicenter Study to Evaluate the Use and Effectiveness of Avatrombopag in Adult Patients with Immune Thrombocytopenia: The Adopt Study
    McDonald, Vickie
    Matzdorff, Axel
    Mellbring, Asa
    Nazir, Jameel
    Lindqvist, Daniel
    Santagostino, Elena
    BLOOD, 2021, 138
  • [3] Interim Analysis of Treatment Satisfaction from a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag or Romiplostim to Avatrombopag
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    BLOOD, 2023, 142
  • [4] Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    BLOOD, 2023, 142
  • [5] Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
    Abdelsamia, Mahmoud
    Farid, Saira
    Dean, Steven
    Cataland, Spero R.
    HEMATOLOGY REPORTS, 2023, 15 (03) : 518 - 523
  • [6] Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia
    Jain, Shivi
    Gernsheimer, Terry
    Kolodny, Scott
    Bernheisel, Chelsea
    Vredenburg, Michael
    Panch, Sandhya R.
    PLATELETS, 2023, 34 (01)
  • [7] Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia
    Eguchi, Yuichiro
    Takahashi, Hirokazu
    Mappa, Silvia
    Santagostino, Elena
    HEPATOLOGY RESEARCH, 2022, 52 (04) : 371 - 380
  • [8] Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study
    Oladapo, Abiola
    Kolodny, Scott
    Vredenburg, Michael
    Swallow, Elyse
    Goldschmidt, Debbie
    Sarathy, Kirthana
    Lopez, Priscilla
    Maitland, Hillary
    Yee, John
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [9] Avatrombopag Treatment Response in Patients with Immune Thrombocytopenia: A Real-World Evidence Study
    Oladapo, Abiola
    Kolodny, Scott
    Vredenburg, Michael
    Jamieson, Brian
    Swallow, Elyse
    Goldschmidt, Debbie
    Zichlin, Miriam L.
    Davidson, Mikhail
    Yu, Louise
    Yee, John
    BLOOD, 2022, 140 : 10889 - 10890
  • [10] Platelet Response to Avatrombopag in Patients with Chronic Immune Thrombocytopenia: Additional Analyses from a Phase 3 Study and Its Extension
    Nagalla, Srikanth
    Vredenburg, Michael
    Tian, Wei
    Allen, Lee F.
    BLOOD, 2019, 134
12345